rCBF SPECT for detection of frontotemporal dementia in people with suspected dementia

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 12, 2013, Pages

  Coulthard, Elizabeth J ^a   Archer, Hilary A ^b   Smailagic, Nadja ^c   John, Christeena ^b   Giannakou, Antri ^d   Holmes, Robin B ^e   Cullum, Sarah ^d  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e Bristol General Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE PROCESSING; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHEOENCEPHALOGRAPHY; SECONDARY HEALTH CARE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SYSTEMATIC REVIEW; TERTIARY HEALTH CARE; X-RAY COMPUTED TOMOGRAPHY;

EID: 85041707282     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010896     Document Type: Article

References (43)

1. Alzheimer's Disease International. World Alzheimer Report 2010. The Global Economic Impact of Dementia. Available from http://www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf.
2. Alzheimer's Society. Dementia UK. http://www.alzheimers.org.uk/site/scripts/download_info.php?fileID=2 (accessed DD-MM-YYYY).
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013. Available from http://dsm.psychiatryonline.org//book.aspx?bookid=556.
4. Catafau AM. Brain SPECT in clinical practice. Part I: perfusion. Journal of Nuclear Medicine 2001;42:259-71.
5. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-80.
6. Davis DHJ, Creavin ST, Noel-Storr A, Quinn TJ, Smailagic N, Hyde C, et al. Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD010460]
7. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-7.
8. Geslani DM, Tierney MC, Herrmann N, Szalai JP. Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2005;19:383-9.
9. Glanville JM, Cikalo M, Crawford F, Dozier M, Lowson P. Handsearching for reports of diagnostic test accuracy studies: adding to the evidence base. Oral presentation at the Joint Cochrane and Campbell Colloquium; 2010 Oct 18-22; Keystone, Colorado, USA [abstract]. Cochrane Database of Systematic Reviews, Supplement. 2010; Vol. Suppl:48.
10. Hendrie HC, Hall KS, Brittain HM, Austrom MG, Farlow M, Parker J, et al. The CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly: a replication with a US sample. Journal of the American Geriatrics Society 1988;36:402-8.
11. Hutchinson AD, Mathias JL. Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review. Journal of Neurology, Neurosurgery & Psychiatry 2007;78:917-28.
12. Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, et al. Procedure guideline for brain perfusion SPECT using (99m)Tc radiopharmaceuticals 3.0. Journal of Nuclear Medicine Technology 2009;37:191-5.
13. Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, et al. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. European Journal of Nuclear Medicine and Molecular Imaging 2009;36:2093-102.
14. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Neurology 2001;56:1143-53.
15. Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54:729-37.
16. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available from: http://srdta.cochrane.org/.
17. Mackenzie IRA, Neumann M, Bigio EH, Cairns NG, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010;119:1-4.
18. Ian R. A. Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Plessis DD, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011;122:111-3.
19. Mahoney CJ, Beck J, 2, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012;135:736-50.
20. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine 2009;6:e1000180.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
22. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia. Archives of Neurology 2001;58:1803-9.
23. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:263-9.
24. Miller BL, Ikonte C, Ponton M, Levy M, Boone K, Darby A, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 1997;48:937-41.
25. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
26. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009;151:264-9.
27. National Audit Office. Improving services and support for people with dementia. 28 June 2007. Available from http://www.nao.org.uk/wp-content/uploads/2007/07/0607604.pdf.
28. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
29. Nedjam Z, Devouche E, Dalla Barba G. Confabulation, but not executive dysfunction discriminate AD from frontotemporal dementia. European Journal of Neurology 2004;11:728-33.
30. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-75.
31. National Institute for Health and Care Excellence. Dementia: Supporting people with dementia and their carers in health and social care. Clinical guidelines CG42. November 2006. Available from http://guidance.nice.org.uk/CG42/NICEGuidance/pdf/English.
32. Okello A, Koivunen J, Edison P, Archer HA, Turkhemer FE, Nagren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study. Neurology 2009;73:754-60.
33. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456-77.
34. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58:1615-21.
35. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58:982-90.
36. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manage (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013.
37. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
38. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. New England Journal of Medicine 2009;360:2302-9.
39. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. Journal of Neurology, Neurosurgery & Psychiatry 2011;82:476-86.
40. The Lund and Manchester Groups. Clinical and neuropathological criteria forfrontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry 1994;57:416-8.
41. Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201-7.
42. Whiting P, Westwood M, Beynon R, Burke M, Sterne JA, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64:602-7.
43. World Health Organization. International Classification of Diseases (ICD). Available from http://www.who.int/entity/classifications/icd/ICD10Volume2_en_2010.pdf.